Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Withdrawn 1 Terminated 1 Enrolling by invitation 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 12 Prostatic Neoplasms 7 Lung Neoplasms 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Recurrence 4 Multiple Myeloma 4 Lymphoma, B-Cell 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Cancer Pain 3 Urologic Neoplasms 2 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Kidney Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenoviridae Infections × 90 days × Clear all

NCT02143804 2026-04-02

exBOND

CG Oncology, Inc.

Phase 2 Withdrawn

Adenoviridae Infections, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡